CPTx develops next generation in vivo CAR T cell therapies, delivering proprietary immune-quiet DNA payloads non-virally with targeting LNPs. The platform offers a more durable alternative to mRNA and supports the delivery of multiple genes. CPTx is advancing a pipeline of differentiated, first-in-class programs across oncology and autoimmune disease, combining deep expertise in DNA vector design, genetic engineering, cancer biology, and immunology to develop next-generation medicines.
| Website | https://www.cptx.bio |
| Employees | 49 (32 on RocketReach) |
| Founded | 2021 |
| Address | SemmelweisstraĆe 1, Planegg, Bavaria 82152, DE |
| Phone | +49 89 69330382 |
| Industry | Biotechnology Research |
| Keywords | Therapeutic Discovery, Nanomedicine, Drug Development, Ai Driven Design, Therapeutic Agents, Drug Delivery, Novel Therapeutics, Biotechnology, Targeted Therapy, Innovative Treatments, Advanced Therapeutics, Precision Medicine, Pharmaceutical Research, Biomedical Engineering, Personalized Medicine, Gene Therapy |
| Competitors | CureVac, Moderna Therapeutics, Novavax, Pfizer, iBio, Inc., Zymergen, Inc., Genentech, Amgen, Zymeworks Inc., AstraZeneca +43 more (view full list) |
Looking for a particular CPTx employee's phone or email?
Christian Sigl is the Co-Founder of CPTx.
32 people are employed at CPTx.
CPTx is based in Planegg, Bavaria.